WATCH THE LATEST FROM BIO 2026
Subscribe to Bio.News Weekly Newsletter
Get Bio.News in your inbox every Monday morning.
SubscribeNo spam. Just science. Unsubscribe at any time.
Latest News
BIO 2026: As capital returns, focus on quality over quantity
“Last year was a very business-as-usual year,” said Daniel Chancellor, VP of Thought Leadership at Norstella, “and has been followed...
BIO 2026: Biotech dealmakers navigate uncertainty, pursue opportunities
From billion-dollar acquisitions to early-stage collaborations, biotech dealmaking is showing renewed momentum despite an increasingly complex policy and regulatory environment....
BIO 2026: The business of biotech runs on partnerships
A $2.5 billion biotech AI deal announced at the beginning of the 2026 BIO International Convention grabbed headlines, but it’s...
BIO 2026 begins in San Diego, marking 50 years of biotech innovation
The Biotechnology Innovation Organization (BIO) International Convention kicks off in San Diego – and 2026 is a special year. “This...
New report details how U.S. can maintain biotech competitiveness
The Reagan-Udall Foundation for the FDA just released a new report on strengthening early-stage drug development in the United States....
BIO 2026: What to know about the AI Summit
“AI systems will likely have a central role over the next several years in almost every component of the biotech...